Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France

[1] Dayyani F(2010)Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC) Head Neck Oncol 2 15-36

[2] Etzel CJ(2009)Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis Int J Cancer 124 1626-8

[3] Liu M(2010)Oropharyngeal carcinoma related to human papillomavirus BMJ 340 c1439-54

[4] Ho CH(2009)Human papillomavirus prevalence and type distribution in penile carcinoma J Clin Pathol 62 870-8

[5] Lippman SM(2013)Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus J Cutan Med Surg 17 S47-22

[6] Tsao AS(2005)Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6 271-6

[7] De Vuyst H(1999)Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients J Clin Microbiol 37 3316-56

[8] Clifford GM(2007)Distribution of human papillomavirus (HPV) genotypes in genital warts from males in Slovenia Acta Dermatovenerol Alp Panonica Adriat 16 91-35

[9] Nascimento MC(2010)Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11 1048-32

[10] Madeleine MM(2011)Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication Int J Cancer 128 927-7

[1] Dayyani F(2010)Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC) Head Neck Oncol 2 15-36

[2] Etzel CJ(2009)Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis Int J Cancer 124 1626-8

[3] Liu M(2010)Oropharyngeal carcinoma related to human papillomavirus BMJ 340 c1439-54

[4] Ho CH(2009)Human papillomavirus prevalence and type distribution in penile carcinoma J Clin Pathol 62 870-8

[5] Lippman SM(2013)Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus J Cutan Med Surg 17 S47-22

[6] Tsao AS(2005)Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6 271-6

[7] De Vuyst H(1999)Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients J Clin Microbiol 37 3316-56

[8] Clifford GM(2007)Distribution of human papillomavirus (HPV) genotypes in genital warts from males in Slovenia Acta Dermatovenerol Alp Panonica Adriat 16 91-35

[9] Nascimento MC(2010)Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11 1048-32

[10] Madeleine MM(2011)Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication Int J Cancer 128 927-7